1 vegetable capsule per serving 30 servings | 20 billion CFU probiotic blend | GOS 200 mg | Ashwagandha root extract 100 mg, least 10% withanolides | Magnesium 33 mg, from magnesium glycinate | Custom order
The phrase ‘gut-brain’ creates a high evidence burden.A basic probiotic approach isn’t enough to help with mood or stress when using any five-strain or multi-strain mix. The current capsule includes 20 billion CFU probiotics along, with GOS, an ashwagandha root extract and a small amount of 33 mg of elemental magnesium. Marketing should clearly show this order. Put the strain information first instead of using general benefits.
| Ingredient | Amount per serving |
| Probiotic blend | 20 billion CFU |
| Galactooligosaccharides (GOS) | 200 mg |
| Ashwagandha root extract | 100 mg / at least 10% withanolides |
| Magnesium from magnesium glycinate | 33 mg elemental magnesium |
| Serving size | 1 vegetable capsule |
| Pack | 30 capsules / 30 servings |
Confirm the complete strain designations before using a gut-brain position. Evidence belongs to the studied strain, dose, population and duration; it cannot be transferred to an unnamed blend solely because both products contain probiotics.
If the exact strains lack appropriate support, keep the public description to a formulation concept: a probiotic-led capsule with prebiotic GOS and two supporting ingredients. Do not convert a category idea into a promised mood result.
The current label specifies 100 mg ashwagandha root extract standardized to at least 10% withanolides. Keep the plant part, extract amount and standardization together. Confirm botanical identity, extraction details, assay method and solvent information from the approved supplier file.
This amount differentiates the formula, but claim review should not borrow outcomes from another extract, dose or daily serving. Destination-market eligibility, warnings and wording also require review.
The Supplement Facts amount is 33 mg elemental magnesium from magnesium glycinate. It is not the total weight of the glycinate ingredient. The raw-material assay determines how much compound enters the blend.
At this level, magnesium is a supporting component. Do not market the product as a high-dose magnesium capsule or use the glycinate compound weight as the nutrient amount.
GOS contributes 200 mg, while the culture, ashwagandha material, magnesium source and excipients make up the rest of the fill. A trial blend is needed to confirm capsule size, flow, fill variation and low-dose distribution.
The 20 billion CFU statement needs a defined declaration point. Water activity, blend room conditions, package barrier, closure and desiccant decision should be set for the final 30-count pack before a shelf-life promise is used.
Commercial copy may describe the labeled ingredients, their formula roles, the need for strain-level evidence and the manufacturing controls used for a custom order. This gives a buyer useful information without pretending that the finished product has already delivered a clinical outcome.
Do not claim treatment of anxiety, depression, chronic stress, insomnia or cognitive disorders. Avoid ‘psychobiotic’ as a proven descriptor unless the exact strain dossier and target-market review support its use.
This formula has no ready-stock designation. MOQ, lead time and sample route are quoted after the target market, strain set, extract source, capsule size, pack and desired claim direction are reviewed.
Send the strain evidence requirements and proposed consumer wording with the enquiry. That lets the technical review identify whether the current concept can support the intended position or needs a different strain or serving structure.
No. The proposed wording must be supported by the exact strains, serving conditions and relevant evidence.
No. It is the elemental magnesium amount. The approved raw-material assay determines the glycinate input weight.
It is a defined differentiator, but this remains a probiotic-led formula. Claims must match the exact extract, dose and target market.
Send the destination market, proposed strains, supporting dossier, CFU basis, desired positioning, pack and expected quantity. HEKONA will review evidence fit, formula feasibility, sampling, MOQ and quotation.
This formula is intended for adults looking for a probiotic-led supplement combined with GOS, ashwagandha and magnesium in a one-capsule serving.
It may suit product lines targeting:
Final target-user wording, directions and claims should be reviewed for the intended sales market before label approval.
Whether you’re exploring new solutions, seeking technical support, or ready to start a project,our team is here to listen and collaborate.
